(2,4-Dibromo-6-fluorophenyl)boronic acid, 95.0%, 10g

1-Boc-4-(carboxythiophen-2-yl-methyl)-[1,4]diazepane, 100mg

2-(1H-Pyrazol-4-yl)-ethanol; hydrochloride, 95.0%, 1g

Butyl 2-cyanoacetate, 95.0%, 1g

3-(3-bromophenyl)-2'-methoxypropiophenone, 97.0%, 1g

6-Bromo-2-methylaminopyridine, 98%, 10g

2-(chloromethyl)-5-[(3-methoxybenzyl)oxy]-4H-pyran-4-one, 95.0%, 500mg

4-CHLORO-5,5-DIMETHYL-5H,6H,7H-PYRROLO[2,3-D]PYRIMIDIN-6-ONE, 95.0%, 10g

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2,3-dimethylbutanoic acid, 95.0%, 1g

Cy-vBRIDP(regR)>90.0%(HPLC)200mg

(S)-3-((tert-Butoxycarbonyl)amino)-4-(2,4,5-trifluorophenyl)butanoic acid, 95.0%, 1g

4-Iodostyrene, 97.0%, 1g

1(4H)-Naphthalenone, 4-[[4-(dimethylamino)phenyl]imino]-, 10g